About Us
We are a team of pioneers, innovators, healthcare champions and market leaders committed to ultrasound excellence and the pursuit of diagnostic confidence.
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is the world leader in diagnostic medical ultrasound technology. With a pioneering approach to multi-parametric ultrasound imaging, SuperSonic Imagine has revolutionized the diagnosis and monitoring of diseases for both practitioners and patients alike. At the heart of SuperSonic Imagine®’s innovations lies UltraFast® Imaging technology, which elevates imaging capabilities to unprecedented levels, boasting a significant increase in frame rates compared to conventional systems.
In its early days, SuperSonic Imagine designed, developed, and brought to market, its first-generation ultrasound system, Aixplorer®, with the capability to acquire images 200 times faster than conventional ultrasound systems, utilizing the patented UltraFast® technology.
This breakthrough enables practitioners to obtain real-time quantitative maps of tissue viscoelastic properties and achieve reproducible quantification of key clinical parameters such as fibrosis or fat content. UltraFast® is the only ultrasound technology that can image using a combination of: conventional (ultrasound waves to image in B-Mode), ShearWave® (with propagation speed linked to the elastic properties of the tissue) and PLanewave UltraSensitive® (a technique that transmits and receives ultrasonic signals at different angles simultaneously, for faster imaging).
SuperSonic Imagine is the pioneer behind the first Real-Time ShearWave® Elastography (SWE™). The combination of UltraFast® and Real-Time ShearWave® ensures excellent image quality with no lag. This allows physicians to visualize and analyze the stiffness of tissue in a reliable, reproducible, non-invasive manner, without delay. Real-Time ShearWave® significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver, and prostate.
Following the Aixplorer® and Aixplorer® Ultimate platform, SuperSonic Imagine released the SuperSonic® MACH® Ultrasound Systems. The SuperSonic® MACH® portfolio is at the forefront of ultrasound imaging across a spectrum of medical specialties including radiology, hepatology, sports medicine, urology, pediatrics, vascular, obstetrics, gynecology, cardiac, and research applications. Equipped with a suite of cutting-edge tools, the SuperSonic® MACH® ultrasound system empowers practitioners to detect, characterize, and classify various pathologies with ease and confidence. Designed with the user in mind, an innovative and optimized user interface features a streamlined console and first-of-its-kind SonicPad™ to improve ergonomics and workflow.
Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital, and NBGI.
With SuperSonic Imagine, the future of ultrasound imaging is here, offering unparalleled precision, efficiency, and reliability in the diagnosis and management of diseases.